ClinConnect ClinConnect Logo
Search / Trial NCT06783946

Meditation Effects on Discomfort, Pain InTerference, and AnxieTy After urEteroscopy

Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Jan 15, 2025

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Meditation Post Operative Pain Ureteroscopy Kidney Stones

ClinConnect Summary

Context:

Pain is common after surgery to remove urinary stones, and current options for post-operative pain management are limited. Pre-operative anxiety is a well-known clinical entity that is associated with a higher risk of post-operative pain. Meditation is an ancient discipline that has been used for a wide range of presumed benefits including improving pain and anxiety. Meditation has been studied in a variety of clinical settings, but its effects have not been assessed among patients having ureteroscopy to remove kidney and/or ureteral stones.

Objectives:

To determine the effect o...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Subjects age 12 years and older
  • 2. Diagnosis of unilateral or bilateral ureteral or renal stones
  • 3. Scheduled to undergo elective unilateral ureteroscopy for renal or ureteral stones in 2 or more weeks from initial clinic visit
  • 4. Parental/guardian permission (informed consent) and if appropriate, child assent.
  • Exclusion Criteria:
  • 1. Participants \<12 years of age
  • 2. Subjects undergoing any other type of stone procedure (i.e. bilateral ureteroscopy, percutaneous nephrolithotomy, ESWL, staged ureteroscopy)
  • 3. Patients who are pre-stented at the initial clinic visit
  • 4. Non-English speaking participants
  • 5. Participants without functional e-mail address or phone
  • 6. Participants unable to use a computer/tablet independently
  • 7. Participants who will be undergoing ureteroscopy in less than 2 weeks from initial clinic visit
  • 8. Patients who are non-verbal or with cognitive delay that may impair ability to learn and adhere to intervention
  • 9. Patients with neurologic comorbidities that may alter sensation (eg. spinal cord injuries)
  • 10. Parents/guardians or subjects who, in the opinion of the investigator, may be non-compliant with study schedules or procedures

About Children's Hospital Of Philadelphia

The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.

Locations

Philadelphia, Pennsylvania, United States

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Gregory E Tasian, MD

Principal Investigator

Children's Hospital of Philadelphia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported